Registration Dossier

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
FDA T.E.S.T Model data
Type of information:
calculation (if not (Q)SAR)
Adequacy of study:
key study
Study period:
July 2020
Reliability:
2 (reliable with restrictions)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2020
Report date:
2020

Materials and methods

Test guideline
Qualifier:
no guideline required
Principles of method if other than guideline:
FDA T.E.S.T Model: Predicted Mutagenicity for C14H29N2O3_1594816693124 for Nearest neighbor method
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
(carboxymethyl)dimethyl-3-[(1-oxooctyl)amino]propylammonium hydroxide
EC Number:
277-600-6
EC Name:
(carboxymethyl)dimethyl-3-[(1-oxooctyl)amino]propylammonium hydroxide
Cas Number:
73772-46-0
Molecular formula:
C14H30N2O3
IUPAC Name:
(carboxymethyl)dimethyl-3-[(1-oxooctyl)amino]propylammonium hydroxide
Test material form:
liquid

Results and discussion

Test results
Key result
Species / strain:
not specified
Metabolic activation:
not specified
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not specified

Applicant's summary and conclusion